单位(元)华宝中证医疗ETF(512170)利润表 |
| 报告期 |
2026/6/30 |
2025/12/31 |
2025/6/30 |
2024/12/31 |
| 收入 |
-2,575,461,972 |
1,501,970,660 |
535,263,357 |
-3,695,187,295 |
| 利息收入 |
520,513 |
1,153,902 |
530,886 |
18,571,674 |
| 其中:存款利息收入 |
520,513 |
1,153,902 |
530,886 |
1,234,971 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益 |
-945,321,447 |
-1,654,014,448 |
-1,594,594,403 |
-3,420,915,675 |
| 其中:股票投资收益 |
-1,167,442,279 |
-2,024,567,441 |
-1,860,814,806 |
-3,775,434,554 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
222,120,832 |
370,552,994 |
266,220,403 |
354,518,879 |
| 公允价值变动收益 |
-1,646,463,975 |
3,127,032,417 |
2,115,325,733 |
-329,725,733 |
| 汇兑收益 |
- |
- |
- |
- |
| 其他收入 |
15,802,937 |
27,798,789 |
14,001,142 |
36,882,439 |
| 费用 |
80,431,013 |
156,562,912 |
77,207,677 |
148,329,769 |
| 管理人报酬 |
66,941,317 |
128,950,538 |
62,899,787 |
117,498,840 |
| 托管费 |
13,388,264 |
25,790,108 |
12,579,957 |
23,499,768 |
| 销售服务费 |
- |
- |
- |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
101,363 |
1,822,266 |
1,727,933 |
7,268,747 |
| 利润总额 |
-2,655,892,985 |
1,345,407,749 |
458,055,681 |
-3,843,517,064 |
| 减:所得税费用 |
- |
- |
- |
- |
| 净利润 |
-2,655,892,985 |
1,345,407,749 |
458,055,681 |
-3,843,517,064 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。